OP
NXTM

Omni Partners’s NxStage Medical Inc. NXTM Stock Holding History

Omni Partners’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-74,521
Closed -$2.08M – 25
2018
Q3 		$2.08M Sell
74,521
-408,310
-85% -$11.5M 0.23% 27
2018
Q2 		$13.5M Buy
482,831
+96,612
+25% +$2.59M 1.52% 15
2018
Q1 		$9.6M Buy
386,219
+47,111
+14% +$1.15M 1.34% 16
2017
Q4 		$8.22M Buy
339,108
+1,215
+0.4% +$32K 1.42% 10
2017
Q3 		$9.33M Buy
+337,893
New +$9.01M 1.19% 17

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Omni Partners's NXTM Position: Q4 2018 in Review

Omni Partners sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 74,521 shares — an estimated $2.08M sold.

Omni Partners first reported a position in NXTM in Q3 2017 and held it in 5 quarters. The position peaked at $13.5M in Q2 2018. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

  • Omni Partners reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
  • Omni Partners sold 74,521 NxStage Medical Inc. shares in Q4 2018, an estimated $2.08M.
  • Omni Partners first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 5 quarters.
  • Omni Partners's NxStage Medical Inc. position peaked at $13.5M in Q2 2018.
  • 172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on Omni Partners's 13F filing for Q4 2018, filed 12 Feb 2019.